PT87496A - Improved flunarizine-cintaining compositions - Google Patents

Improved flunarizine-cintaining compositions

Info

Publication number
PT87496A
PT87496A PT87496A PT8749688A PT87496A PT 87496 A PT87496 A PT 87496A PT 87496 A PT87496 A PT 87496A PT 8749688 A PT8749688 A PT 8749688A PT 87496 A PT87496 A PT 87496A
Authority
PT
Portugal
Prior art keywords
flunarizine
cintaining
compositions
improved
alcohol
Prior art date
Application number
PT87496A
Other languages
English (en)
Other versions
PT87496B (pt
Inventor
Jean Mesens
Achiel Paul Van Peer
Josef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT87496A publication Critical patent/PT87496A/pt
Publication of PT87496B publication Critical patent/PT87496B/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fertilizers (AREA)
PT87496A 1987-05-18 1988-05-17 Processo para a preparacao de composicoes aperfeicoadas que contem flumarizina PT87496B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5064487A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
PT87496A true PT87496A (pt) 1989-05-31
PT87496B PT87496B (pt) 1992-09-30

Family

ID=21966482

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87496A PT87496B (pt) 1987-05-18 1988-05-17 Processo para a preparacao de composicoes aperfeicoadas que contem flumarizina

Country Status (19)

Country Link
EP (1) EP0292050B1 (pt)
JP (1) JPS63303926A (pt)
KR (1) KR880013559A (pt)
AT (1) ATE69555T1 (pt)
AU (1) AU603895B2 (pt)
DE (1) DE3866281D1 (pt)
DK (1) DK268788A (pt)
ES (1) ES2051827T3 (pt)
FI (1) FI882307L (pt)
GR (1) GR3003482T3 (pt)
HU (1) HU199073B (pt)
IE (1) IE60937B1 (pt)
IL (1) IL86395A (pt)
NO (1) NO882134L (pt)
NZ (1) NZ224497A (pt)
PH (1) PH24425A (pt)
PT (1) PT87496B (pt)
RU (1) RU1829935C (pt)
ZA (1) ZA883492B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532002A (en) * 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
CA2063791C (en) * 1989-08-17 2000-12-19 Michael John Story Hard gelatine capsule containing fat-soluble nutrients.
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
US6596706B1 (en) * 1997-11-07 2003-07-22 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
CN100519561C (zh) * 2001-09-10 2009-07-29 泰博特克药品有限公司 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
ES2661812T3 (es) 2009-10-16 2018-04-04 Mochida Pharmaceutical Co., Ltd. Composiciones
CN104069086A (zh) * 2014-07-22 2014-10-01 周有财 一种盐酸氟桂利嗪组合物胶囊及其制备方法
CN113262207B (zh) * 2020-02-17 2022-06-17 正大青春宝药业有限公司 一种盐酸氟桂利嗪胶囊制剂及其制备方法
CN115381791B (zh) * 2022-09-21 2023-06-16 迪沙药业集团有限公司 一种盐酸氟桂利嗪药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
EP0366156B1 (de) * 1984-01-28 1995-01-11 Roshdy Dr. Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5047229A (en) * 1986-12-17 1991-09-10 Miles, Inc. Treatment of cardiovascular and cerebral toxicity using calcium modulators

Also Published As

Publication number Publication date
FI882307A7 (fi) 1988-11-19
IE881477L (en) 1988-11-18
RU1829935C (ru) 1993-07-23
DK268788D0 (da) 1988-05-17
PT87496B (pt) 1992-09-30
HUT46851A (en) 1988-12-28
DE3866281D1 (de) 1992-01-02
ATE69555T1 (de) 1991-12-15
AU1613288A (en) 1988-11-24
KR880013559A (ko) 1988-12-21
PH24425A (en) 1990-06-25
NO882134L (no) 1988-11-21
NO882134D0 (no) 1988-05-16
GR3003482T3 (en) 1993-02-17
DK268788A (da) 1988-11-19
IL86395A0 (en) 1988-11-15
FI882307A0 (fi) 1988-05-17
IL86395A (en) 1992-11-15
AU603895B2 (en) 1990-11-29
JPS63303926A (ja) 1988-12-12
FI882307L (fi) 1988-11-19
EP0292050B1 (en) 1991-11-21
NZ224497A (en) 1990-04-26
IE60937B1 (en) 1994-09-07
ES2051827T3 (es) 1994-07-01
ZA883492B (en) 1990-01-31
EP0292050A1 (en) 1988-11-23
HU199073B (en) 1990-01-29

Similar Documents

Publication Publication Date Title
ATE69555T1 (de) Flunarizin enthaltende zusammensetzungen.
SG25893G (en) Sulfurized compositions,and additive concentrates and lubricating oils containing same
NO180804C (no) Fettsyreblandinger
DK0658097T3 (da) Deodoriserende kosmetiske midler med et indhold af fedtsyrer
DK581185D0 (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
DK453589D0 (da) Biocidsammensaetninger
KR910005747A (ko) 조립(造粒) 코팅된 종자
ES8603240A1 (es) Un metodo para preparar una formulacion ectoparasiticida
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
KR880008795A (ko) 피부 화장료
DE69300005D1 (de) Fettarmer Brotaufstrich.
DE3778826D1 (de) Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung.
FR2399802A1 (fr) Compositions insecticides presentant un effet de synergie
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients
ES8601692A1 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
KR830003868A (ko) 살충성을 지닌 u.l.v 조성물
JPS6416564A (en) Composition for food additive
KR910012222A (ko) 화장비누 조성물
SG88894G (en) Mixtures of partial fatty acid esters of polyhydric alcohols and sulfurized compositions, and use as lubricant additives.
ATE189383T1 (de) Schweisshemmende cremezusammensetzungen enthaltend triglycerid gelierungsmittel
IT1207764B (it) Derivati di estere fosforico e composizioni insetticida e acaricida contenenti tali derivati.
BG28979A3 (bg) Инсектицидно средство
KR850002952A (ko) 불안정한 활성성분을 함유한 젤상 외용제의 제조방법

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920302

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970930